Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children

Safety and Effectiveness of Ferumoxytol in Hemodialysis Patients at 3 Dialysis Chains in the United States Over a 12-Month Period

(2013) Brigitte Schiller et al.   CLINICAL THERAPEUTICS

Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases

(2013) Mustafa R. Bashir et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Ferumoxytol in clinical practice: Implications for MRI

(2012) Brendan J. McCullough et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

USPIO-enhanced MR Angiography of Arteriovenous Fistulas in Patients with Renal Failure

(2012) Monica Sigovan et al.   RADIOLOGY

Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival

(2012) Seymur Gahramanov et al.   RADIOLOGY

Comparative Analysis of Ferumoxytol and Gadoteridol Enhancement Using T1- and T2-Weighted MRI in Neuroimaging

(2011) Bronwyn E. Hamilton et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Ferumoxytol Use as an Intravenous Contrast Agent for Magnetic Resonance Angiography

(2011) Katie L Stabi et al.   ANNALS OF PHARMACOTHERAPY